InnovAge Holding Corp. (INNV)
24.19 0.00 (0.00%)
After hours: 4:00PM EDT
Chart Events
Performance Outlook
| Previous Close | 23.76 |
| Open | 23.91 |
| Bid | 23.55 x 800 |
| Ask | 39.00 x 800 |
| Day's Range | 23.56 - 24.49 |
| 52 Week Range | 20.86 - 27.18 |
| Volume | 105,145 |
| Avg. Volume | 796,747 |
| Market Cap | 3.681B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.16 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2021
Upgrades According to Citigroup, the prior rating for GSX Techedu Inc (NYSE:GSX) was changed from Sell to Buy. In the fourth quarter, GSX Techedu showed an EPS of $0.39, compared to $0.70 from the year-ago quarter. The stock has a 52-week-high of $149.05 and a 52-week-low of $27.06. At the end of the last trading period, GSX Techedu closed at $39.00. According to Loop Capital, the prior rating for ViacomCBS Inc (NASDAQ:VIAC) was changed from Sell to Hold. For the fourth quarter, ViacomCBS had an EPS of $1.04, compared to year-ago quarter EPS of $0.97. The stock has a 52-week-high of $101.97 and a 52-week-low of $11.92. At the end of the last trading period, ViacomCBS closed at $48.23. Loop Capital upgraded the previous rating for Baidu Inc (NASDAQ:BIDU) from Hold to Buy. Baidu earned $3.08 in the fourth quarter, compared to $3.81 in the year-ago quarter. The current stock performance of Baidu shows a 52-week-high of $354.82 and a 52-week-low of $90.94. Moreover, at the end of the last trading period, the closing price was at $208.61. For PTC Therapeutics Inc (NASDAQ:PTCT), RBC Capital upgraded the previous rating of Underperform to Sector Perform. In the fourth quarter, PTC Therapeutics showed an EPS of $1.08, compared to $1.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $70.82 and a 52-week-low of $40.03. PTC Therapeutics closed at $49.21 at the end of the last trading period. For Harmony Biosciences Holdings Inc (NASDAQ:HRMY), Goldman Sachs upgraded the previous rating of Neutral to Buy. In the fourth quarter, Harmony Biosciences earned $0.25. The stock has a 52-week-high of $52.74 and a 52-week-low of $26.51. At the end of the last trading period, Harmony Biosciences closed at $27.56. Truist Securities upgraded the previous rating for Twitter Inc (NYSE:TWTR) from Hold to Buy. For the fourth quarter, Twitter had an EPS of $0.38, compared to year-ago quarter EPS of $0.25. At the moment, the stock has a 52-week-high of $80.75 and a 52-week-low of $22.36. Twitter closed at $61.31 at the end of the last trading period. Morgan Stanley upgraded the previous rating for Carrier Global Corp (NYSE:CARR) from Equal-Weight to Overweight. Carrier Global earned $0.31 in the fourth quarter. The stock has a 52-week-high of $41.94 and a 52-week-low of $12.26. At the end of the last trading period, Carrier Global closed at $41.14. Morgan Stanley upgraded the previous rating for Johnson Controls International PLC (NYSE:JCI) from Equal-Weight to Overweight. For the first quarter, Johnson Controls Intl had an EPS of $0.43, compared to year-ago quarter EPS of $0.40. The stock has a 52-week-high of $62.40 and a 52-week-low of $24.66. At the end of the last trading period, Johnson Controls Intl closed at $59.99. According to Compass Point, the prior rating for Cowen Inc (NASDAQ:COWN) was changed from Neutral to Buy. In the fourth quarter, Cowen showed an EPS of $4.58, compared to $0.58 from the year-ago quarter. The stock has a 52-week-high of $43.17 and a 52-week-low of $8.46. At the end of the last trading period, Cowen closed at $34.34. For Otis Worldwide Corp (NYSE:OTIS), HSBC upgraded the previous rating of Reduce to Hold. Otis Worldwide earned $0.66 in the fourth quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $69.38 and a 52-week-low of $41.26. At the end of the last trading period, Otis Worldwide closed at $69.05. Morgan Stanley upgraded the previous rating for Array Technologies Inc (NASDAQ:ARRY) from Underweight to Equal-Weight. In the fourth quarter, Array Technologies earned $0.08. At the moment, the stock has a 52-week-high of $54.78 and a 52-week-low of $26.13. Array Technologies closed at $28.46 at the end of the last trading period. CLSA upgraded the previous rating for Sea Ltd (NYSE:SE) from Outperform to Buy. Sea earned $0.87 in the fourth quarter, compared to $0.53 in the year-ago quarter. The stock has a 52-week-high of $285.00 and a 52-week-low of $40.41. At the end of the last trading period, Sea closed at $208.82. For ViacomCBS Inc (NASDAQ:VIAC), BMO Capital upgraded the previous rating of Underperform to Market Perform. In the fourth quarter, ViacomCBS showed an EPS of $1.04, compared to $0.97 from the year-ago quarter. The current stock performance of ViacomCBS shows a 52-week-high of $101.97 and a 52-week-low of $11.92. Moreover, at the end of the last trading period, the closing price was at $48.23. For Franklin Resources Inc (NYSE:BEN), BMO Capital upgraded the previous rating of Market Perform to Outperform. For the first quarter, Franklin Resources had an EPS of $0.73, compared to year-ago quarter EPS of $0.70. The current stock performance of Franklin Resources shows a 52-week-high of $30.55 and a 52-week-low of $14.91. Moreover, at the end of the last trading period, the closing price was at $29.43. Goldman Sachs upgraded the previous rating for Ovintiv Inc (NYSE:OVV) from Neutral to Buy. Ovintiv earned $0.70 in the fourth quarter, compared to $0.81 in the year-ago quarter. The current stock performance of Ovintiv shows a 52-week-high of $28.69 and a 52-week-low of $2.39. Moreover, at the end of the last trading period, the closing price was at $24.26. According to Deutsche Bank, the prior rating for Everest Re Group Ltd (NYSE:RE) was changed from Hold to Buy. In the fourth quarter, Everest Re Group showed an EPS of $1.12, compared to $3.20 from the year-ago quarter. The stock has a 52-week-high of $256.60 and a 52-week-low of $157.32. At the end of the last trading period, Everest Re Group closed at $249.68. See all analyst ratings upgrades. Downgrades For Co-Diagnostics Inc (NASDAQ:CODX), Maxim Group downgraded the previous rating of Buy to Hold. Co-Diagnostics earned $0.43 in the fourth quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $30.99 and a 52-week-low of $6.81. At the end of the last trading period, Co-Diagnostics closed at $9.70. For Ares Management Corp (NYSE:ARES), BMO Capital downgraded the previous rating of Outperform to Market Perform. Ares Management earned $0.54 in the fourth quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $55.96 and a 52-week-low of $28.50. At the end of the last trading period, Ares Management closed at $53.93. For Adecoagro SA (NYSE:AGRO), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the fourth quarter, Adecoagro had an EPS of $0.26, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $9.64 and a 52-week-low of $3.31. Adecoagro closed at $7.91 at the end of the last trading period. See all analyst ratings downgrades. Initiations With a Sell rating, BWS Financial initiated coverage on Calix Inc (NYSE:CALX). The price target seems to have been set at $13.00 for Calix. Calix earned $0.45 in the fourth quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $48.78 and a 52-week-low of $6.36. At the end of the last trading period, Calix closed at $38.45. With an Outperform rating, Credit Suisse initiated coverage on Oscar Health Inc (NYSE:OSCR). The price target seems to have been set at $34.00 for Oscar Health. The current stock performance of Oscar Health shows a 52-week-high of $37.00 and a 52-week-low of $22.56. Moreover, at the end of the last trading period, the closing price was at $25.68. With a Buy rating, Goldman Sachs initiated coverage on InnovAge Holding Corp (NASDAQ:INNV). The price target seems to have been set at $32.00 for InnovAge Holding. The current stock performance of InnovAge Holding shows a 52-week-high of $27.18 and a 52-week-low of $20.86. Moreover, at the end of the last trading period, the closing price was at $24.35. Goldman Sachs initiated coverage on Oscar Health Inc (NYSE:OSCR) with a Buy rating. The price target for Oscar Health is set to $44.00. At the moment, the stock has a 52-week-high of $37.00 and a 52-week-low of $22.56. Oscar Health closed at $25.68 at the end of the last trading period. Daiwa Capital initiated coverage on DocuSign Inc (NASDAQ:DOCU) with a Buy rating. The price target for DocuSign is set to $239.00. DocuSign earned $0.37 in the fourth quarter, compared to $0.12 in the year-ago quarter. At the moment, the stock has a 52-week-high of $290.23 and a 52-week-low of $78.72. DocuSign closed at $201.96 at the end of the last trading period. For InnovAge Holding Corp (NASDAQ:INNV), Barclays initiated coverage, by setting the current rating at Equal-Weight. The current stock performance of InnovAge Holding shows a 52-week-high of $27.18 and a 52-week-low of $20.86. Moreover, at the end of the last trading period, the closing price was at $24.35. HC Wainwright & Co. initiated coverage on Scorpio Tankers Inc (NYSE:STNG) with a Buy rating. The price target for Scorpio Tankers is set to $28.00. For the fourth quarter, Scorpio Tankers had an EPS of $1.41, compared to year-ago quarter EPS of $0.23. The current stock performance of Scorpio Tankers shows a 52-week-high of $28.21 and a 52-week-low of $8.28. Moreover, at the end of the last trading period, the closing price was at $19.76. With a Neutral rating, HC Wainwright & Co. initiated coverage on Ardmore Shipping Corp (NYSE:ASC). The price target seems to have been set at $5.50 for Ardmore Shipping. For the fourth quarter, Ardmore Shipping had an EPS of $0.39, compared to year-ago quarter EPS of $0.08. The current stock performance of Ardmore Shipping shows a 52-week-high of $7.92 and a 52-week-low of $2.61. Moreover, at the end of the last trading period, the closing price was at $4.99. HC Wainwright & Co. initiated coverage on Diamond S Shipping Inc (NYSE:DSSI) with a Buy rating. The price target for Diamond S Shipping is set to $16.50. In the fourth quarter, Diamond S Shipping showed an EPS of $0.71, compared to $0.75 from the year-ago quarter. The stock has a 52-week-high of $15.50 and a 52-week-low of $5.31. At the end of the last trading period, Diamond S Shipping closed at $9.62. With a Buy rating, HC Wainwright & Co. initiated coverage on Tsakos Energy Navigation Ltd (NYSE:TNP). The price target seems to have been set at $18.00 for Tsakos Energy Navigation. For the fourth quarter, Tsakos Energy Navigation had an EPS of $1.08, compared to year-ago quarter EPS of $0.34. At the moment, the stock has a 52-week-high of $11.02 and a 52-week-low of $1.91. Tsakos Energy Navigation closed at $9.98 at the end of the last trading period. With a Neutral rating, HC Wainwright & Co. initiated coverage on Nordic American Tankers Ltd (NYSE:NAT). The price target seems to have been set at $3.75 for Nordic American Tankers. For the fourth quarter, Nordic American Tankers had an EPS of $0.19, compared to year-ago quarter EPS of $0.09. The current stock performance of Nordic American Tankers shows a 52-week-high of $9.00 and a 52-week-low of $2.75. Moreover, at the end of the last trading period, the closing price was at $3.87. HC Wainwright & Co. initiated coverage on International Seaways Inc (NYSE:INSW) with a Buy rating. The price target for International Seaways is set to $30.00. In the fourth quarter, International Seaways showed an EPS of $0.52, compared to $1.32 from the year-ago quarter. The current stock performance of International Seaways shows a 52-week-high of $29.30 and a 52-week-low of $12.44. Moreover, at the end of the last trading period, the closing price was at $19.99. With a Neutral rating, HC Wainwright & Co. initiated coverage on Frontline Ltd (NYSE:FRO). The price target seems to have been set at $8.00 for Frontline. In the fourth quarter, Frontline showed an EPS of $0.10, compared to $0.54 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.95 and a 52-week-low of $5.28. Frontline closed at $8.09 at the end of the last trading period. With a Buy rating, HC Wainwright & Co. initiated coverage on Euronav NV (NYSE:EURN). The price target seems to have been set at $13.00 for Euronav. Euronav earned $0.29 in the fourth quarter, compared to $0.75 in the year-ago quarter. The stock has a 52-week-high of $12.47 and a 52-week-low of $7.21. At the end of the last trading period, Euronav closed at $9.57. HC Wainwright & Co. initiated coverage on DHT Holdings Inc (NYSE:DHT) with a Neutral rating. The price target for DHT Holdings is set to $7.50. In the fourth quarter, DHT Holdings showed an EPS of $0.04, compared to $0.47 from the year-ago quarter. The current stock performance of DHT Holdings shows a 52-week-high of $8.68 and a 52-week-low of $4.52. Moreover, at the end of the last trading period, the closing price was at $6.51. Benchmark initiated coverage on Esports Entertainment Group Inc (NASDAQ:GMBL) with a Buy rating. The price target for Esports Entertainment is set to $20.00. Esports Entertainment earned $0.57 in the second quarter. The current stock performance of Esports Entertainment shows a 52-week-high of $24.48 and a 52-week-low of $2.40. Moreover, at the end of the last trading period, the closing price was at $14.80. JP Morgan initiated coverage on CytomX Therapeutics Inc (NASDAQ:CTMX) with an Overweight rating. The price target for CytomX Therapeutics is set to $14.00. CytomX Therapeutics earned $0.31 in the fourth quarter, compared to $0.79 in the year-ago quarter. The current stock performance of CytomX Therapeutics shows a 52-week-high of $15.44 and a 52-week-low of $5.95. Moreover, at the end of the last trading period, the closing price was at $7.62. With a Buy rating, Citigroup initiated coverage on InnovAge Holding Corp (NASDAQ:INNV). The price target seems to have been set at $30.00 for InnovAge Holding. The stock has a 52-week-high of $27.18 and a 52-week-low of $20.86. At the end of the last trading period, InnovAge Holding closed at $24.35. With a Buy rating, Deutsche Bank initiated coverage on Cracker Barrel Old Country Store Inc (NASDAQ:CBRL). The price target seems to have been set at $195.00 for Cracker Barrel Old. For the second quarter, Cracker Barrel Old had an EPS of $0.70, compared to year-ago quarter EPS of $2.70. The current stock performance of Cracker Barrel Old shows a 52-week-high of $175.00 and a 52-week-low of $67.32. Moreover, at the end of the last trading period, the closing price was at $172.03. With a Buy rating, Truist Securities initiated coverage on Aspira Womens Health Inc (NASDAQ:AWH). The price target seems to have been set at $12.00 for Aspira Womens Health. Aspira Womens Health earned $0.58 in the fourth quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $10.54 and a 52-week-low of $2.47. Aspira Womens Health closed at $6.81 at the end of the last trading period. JonesTrading initiated coverage on Ocuphire Pharma Inc (NASDAQ:OCUP) with a Buy rating. The price target for Ocuphire Pharma is set to $20.00. The current stock performance of Ocuphire Pharma shows a 52-week-high of $13.81 and a 52-week-low of $5.07. Moreover, at the end of the last trading period, the closing price was at $5.84. William Blair initiated coverage on InnovAge Holding Corp (NASDAQ:INNV) with an Outperform rating. At the moment, the stock has a 52-week-high of $27.18 and a 52-week-low of $20.86. InnovAge Holding closed at $24.35 at the end of the last trading period. With an Overweight rating, Piper Sandler initiated coverage on InnovAge Holding Corp (NASDAQ:INNV). The price target seems to have been set at $31.00 for InnovAge Holding. At the moment, the stock has a 52-week-high of $27.18 and a 52-week-low of $20.86. InnovAge Holding closed at $24.35 at the end of the last trading period. HC Wainwright & Co. initiated coverage on Performance Shipping Inc (NASDAQ:PSHG) with a Buy rating. The price target for Performance Shipping is set to $11.00. Performance Shipping earned $0.51 in the fourth quarter, compared to $0.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.11 and a 52-week-low of $0.42. Performance Shipping closed at $5.59 at the end of the last trading period. See all analyst ratings initiations. See more from BenzingaClick here for options trades from BenzingaEarnings Preview for Osmotica Pharmaceuticals5 Value Stocks To Watch In The Communication Services Sector© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- GlobeNewswire
InnovAge Announces Exercise of Underwriters’ Option to Purchase Additional Shares
DENVER, March 12, 2021 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (Nasdaq: INNV) today announced that on March 9, 2021, the underwriters of the previously announced initial public offering of 16,666,667 shares of its common stock exercised their option to purchase an additional 2,329,234 shares of common stock from InnovAge at the initial public offering price of $21.00 per share, less underwriting discounts and commissions. Including the exercise of the over-allotment option, InnovAge has issued a total of 18,995,901 shares, for gross proceeds of approximately $399 million before deducting underwriting discounts and commissions. The shares are listed for trading on the Nasdaq Global Select Market under the symbol “INNV.” J.P. Morgan Securities LLC, Barclays Capital Inc., Goldman Sachs & Co. LLC and Citigroup acted as joint lead book-running managers of the offering and as representatives of the underwriters. Robert W. Baird & Co. Incorporated, William Blair & Company, L.L.C., Piper Sandler & Co. and Capital One Securities, Inc. acted as joint book-running managers of the offering. Loop Capital Markets LLC, Siebert Williams Shank & Co., LLC and Roberts & Ryan Investments, Inc. acted as co-managers of the offering. The offering of these securities was made only by means of a prospectus. Copies of the prospectus relating to this offering may be obtained from: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 1-866- 803-9204 or email at prospectus-eq_fi@jpmchase.com; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by email at barclaysprospectus@broadridge.com or by telephone at 1-888-603-5847; or Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, via telephone: 1-866-471-2526, or via email: prospectus-ny@ny.email.gs.com; or Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (800) 831-9146. A registration statement relating to these securities was filed with, and declared effective by, the Securities and Exchange Commission on March 3, 2021. Copies of the registration statement can be accessed through the Securities and Exchange Commission’s website at www.sec.gov. This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended. About InnovAge InnovAge is a market leader in managing the care of high-cost, dual-eligible seniors. Our mission is to enable seniors to age independently in their own homes for as long as possible. Our patient-centered care model meaningfully improves the quality of care our participants receive, while reducing over-utilization of high-cost care settings. InnovAge is at the forefront of value based senior healthcare and directly contracts with government payors, such as Medicare and Medicaid, to manage the totality of a participant’s medical care. InnovAge believes its healthcare model is one in which all constituencies — participants, their families, providers and government payors—“Win.” InnovAge currently serves approximately 6,600 participants across 17 centers in five states. Media Contacts: Mark CorbaeMark.Corbae@westwicke.com Kyle EvansKyle.Evans@westwicke.com Investor Contacts: Bob East, Asher Dewhurst, Jordan KohnstamInnovAgeIRPR@westwicke.com
- Barrons.com
InnovAge, an Elder-Care IPO, Gains on First Day
The company, the second to make its markets debut this week, collected $350 million after pricing its offering above the range it had told investors to expect.
